2010/06/06

EUCAZOLIN

Pharmacological properties: The drug has α-adrenomimetics action narrows the peripheral vessels. When applied to the mucous membrane due to the vasoconstrictive effect reduces swelling of mucous membranes, congestion, exudation, facilitates nasal breathing. Thanks to its constituent of eucalyptus oil product removes dry nasal mucosa and has anti-inflammatory and antibacterial effect.

It acts mainly locally, when used in therapeutic doses absorbed through the mucous membranes in small quantities. The action begins in a few minutes after application, lasts for 8-10 hours

INDICATIONS: acute rhinitis and rhinosinusitis, pollinosis, otitis media (to reduce swelling of the mucous membrane nasopharynx); preparing the patient for diagnostic and therapeutic procedures in the nasal passages.

APPLICATION: Evkazolin drops

Adults and children over 12 years - 1-2 drops 2-3 times a day in each nasal passage.

Children aged 7 to 12 years - 1 drop in each nasal passage 2-3 times a day. The drug is used within 5-7 days.

Evkazolin Aqua Spray

Adults and children over the age of 12 years, appoint 1 injection of 2-3 times per day in each nasal passage. The duration of the drug - 5-7 days.

Contraindications: angle-closure glaucoma, atrophic rhinitis, hypersensitivity to the drug's components, hypertension, hyperthyroidism, the age of 7 years.

SIDE EFFECTS: irritation, dryness of the nasal mucosa, burning, stinging, sneezing, hypersecretion. In rare cases, possible swelling of the nasal mucosa and a violation of smell, mucosal atrophy (often with prolonged use), tachycardia, arrhythmia, increased blood pressure, headache, vomiting, sleep disturbances, and vision, allergic reactions.

SPECIAL PRECAUTIONS: Prolonged use of the drug develops tolerance to it (reducing the effectiveness or lack of effect).

Use during pregnancy and lactation: therapeutic doses of the drug acts locally and does not have a systemic impact, so the use of the drug in therapeutic doses in this group does not contraindicated.

In patients with hypertension, hyperthyroidism, disorders of the cardiovascular system, diabetes medication should be used with caution given the possibility of hypertension, tachycardia, and arrhythmias.

INTERACTION: Evkazolin interacts with other drugs only if the resorptive effect. Sympathomimetics other groups reinforce the effect Evkazolina. Adrenolitiki and sympatholytic, antagonists of calcium ions reduce its effect. Evkazolin weakens the action and psychoactive effects of tricyclic antidepressants, MAO effect on the cardiovascular system. Sympathomimetics should not be used in conjunction with sedation (reduction efficiency).

OVERDOSE: If you use the drug may show symptoms of an overdose in the form of headache, dryness in the nose, nausea, depression, improve blood pressure, short-term impairment, may increase the intraocular pressure. Must stop using the product and to appoint agents antagonists: blockers and sympatholytic α-adrenergic receptors (fentolamin, thropaphen), symptomatic therapy. If the drug is accidentally taken by mouth, wash the stomach, to appoint enterosorbents and laxatives, α-adrenoceptor blockers and symptomatic therapy. Frequent peredozrovka can lead to atrophy of the nasal mucosa.

Storage: Store in dark place at a temperature of 15-25 ° C.